Abattis Bioceuticals Corp.
ATTBF
Rank in Stocks
#35227
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology... Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
Share Price
$0.000001
Last synced: 2026-11-09
Market Cap
$477.88
Change (1 day)
-96.67%
Change (1 year)
-96.67%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Abattis Bioceuticals Corp. (ATTBF)
Category
Healthcare
EPS for Abattis Bioceuticals Corp. (ATTBF)
EPS as of September 2019 TTM: $0.00
According to Abattis Bioceuticals Corp.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2019 the company had an EPS of 0.00, an increase over its 2018 EPS of $-0.19.
EPS history for Abattis Bioceuticals Corp. from 2008 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -97.38% |
| 2019 | 0.00 | -97.38% |
| 2018 | $-0.19 | 353.64% |
| 2017 | $-0.04 | 120.32% |
| 2016 | $-0.02 | -61.60% |
| 2015 | $-0.05 | -65.94% |
| 2014 | $-0.14 | 248.78% |
| 2013 | $-0.04 | -55.09% |
| 2012 | $-0.09 | -31.87% |
| 2011 | $-0.13 | -7.97% |
| 2010 | $-0.15 | -40.01% |
| 2009 | $-0.24 | 1,974.36% |
| 2008 | $-0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $1.69 | -34,589.80% |
US
|
|
| $1.93 | -39,504.08% |
SE
|
|
| $6.91 | -141,202.04% |
FR
|
|
| $0.02 | -497.96% |
HK
|
|
| $2.71 | -55,402.04% |
IT
|
Questions about Abattis Bioceuticals Corp.'s earnings per share (EPS)
What is Abattis Bioceuticals Corp.'s earnings per share (EPS)?
Abattis Bioceuticals Corp.'s earnings per share (EPS) over the last twelve months is $0.00, as of Sep 2019.
What was Abattis Bioceuticals Corp.'s earnings per share (EPS) in 2019?
In 2019, Abattis Bioceuticals Corp.'s earnings per share (EPS) was 0.00, compared with $-0.19 in 2018.
How has Abattis Bioceuticals Corp.'s earnings per share (EPS) changed since 2014?
From 2014 to 2019, Abattis Bioceuticals Corp.'s earnings per share (EPS) was highest in 2019 (0.00) and lowest in 2018 ($-0.19).
How does Abattis Bioceuticals Corp.'s earnings per share (EPS) compare with similar companies?
Abattis Bioceuticals Corp.'s earnings per share (EPS) ($0.00) is lower than that of all 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.91.